南京聚隆(300644.SZ)擬與南京東聚共設聚隆復材
格隆匯 8 月 25日丨南京聚隆(300644.SZ)公佈,根據公司戰略發展需要,公司擬與南京東聚碳纖維複合材料研究院有限公司(“南京東聚”)共同出資設立“南京聚隆複合材料科技有限公司”(暫定名,以工商核名為準。“聚隆復材”)。聚隆復材擬註冊資本為人民幣2000萬元,其中公司現金出資1600萬元,佔比80%;南京東聚現金出資400萬元,佔比20%。
公司此次對外投資設立控股子公司將利用出資雙方的資源優勢,藉助複合材料戰略性的發展前景,以國產碳纖維為原料,生產先進複合材料,以適應航空航天與軌道交通主要應用領域的市場需求,從而增加公司銷售和利潤增長點,符合公司戰略規劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.